We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Integrated Database Helps Detect Biomarkers to Neurological Diseases

By LabMedica International staff writers
Posted on 20 May 2009
A searchable, integrated database of human genes provides concise genomic, proteomic, transcriptomic, genetic, and functional information on all known and predicted human genes. More...
It will be used to identify and characterize protein biomarkers for serious neurological diseases.

Information featured in the database, which is called GeneCards, includes orthologies, disease relationships, mutations and single nucleotide polymorphisms (SNPs), gene expression, gene function, pathways, protein-protein interactions, related drugs and compounds, and direct links to research reagents and tools such as antibodies, recombinant proteins, clones, expression assays and RNAi reagents.

GeneCards was developed by a bioinformatics team at the Weizmann Institute of Science (Rehovot, Israel) directed by Marilyn Safran and Prof. Doron Lancet of the department of molecular genetics, and head of the Crown Human Genome Center.

Xennex (Cambridge MA, USA) has provided Satoris (Redwood City, CA, USA) with access to GeneCards and associated tools. Satoris is utilizing GeneCards and the related technology for investigations related to its identification and characterization of protein biomarkers associated with neurological disease such as Alzheimer's, Parkinson's, multiple sclerosis, and diabetic neuropathy, to create new diagnostic tools for earlier, better healthcare decisions.

The newly released GeneCards Version 3.0 features a significantly upgraded infrastructure, including a comprehensive relational biological database, and a sophisticated, and speedier search engine. It provides capabilities for effective and well-targeted queries, a user-friendly display, and clear data navigation. Also released, a preliminary version of GeneDecks Version 3, which makes use of the new GeneCards relational database for complex analyses on sets of genes.

Dr. David Warshawsky, president & CEO of Xennex, stated: "We are very pleased that we can offer Satoris our most advanced tools and the latest GeneCards developments to assist in their work. Satoris' work is of great potential for improved diagnosis and treatment of devastating conditions."

Related Links:

GeneCards
Weizmann Institute of Science
Xennex
Satoris



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.